Objective. The purpose of this analysis was to evaluate the experience of opioid-induced constipation in younger patients and identify differences in the experience of opioid-induced constipation and its symptoms between younger patients (<50 years) and older patients (50-64 years).
Introduction
Chronic noncancer pain represents a substantial health care problem, with an estimated 25 million Americans experiencing daily chronic pain, based on data from the 2012 National Health Interview Survey [1] . Chronic pain is associated with substantial negative effects on patient functioning, health-related quality of life (HRQL), and productivity [2] [3] [4] [5] . In a survey including 359 US patients with chronic pain, approximately 70% to 90% of these chronic pain patients reported that their pain had a negative impact on day-to-day activities at least some of the time [4] .
Opioids are an appropriate component of pain management for select patients with chronic noncancer pain [6, 7] . The patients who use opioids as a part of the chronic pain management regimen may experience serious side effects that limit their quality of life, including opioid-induced constipation (OIC) [8] . While the majority of opioid-related side effects resolve over the course of opioid therapy, OIC generally persists and may be particularly problematic for patients receiving long-term opioid therapy for chronic pain [9] . OIC affects from 40% to 80% of patients taking opioid analgesics for chronic noncancer pain [10] [11] [12] and is often refractory to conventional interventions for constipation, including increased dietary fiber and laxatives [13] . Patients may stop taking opioid therapy or reduce their dose to avoid constipation, which may result in inadequate pain management [10, 14, 15] . In a survey of 322 patients with chronic pain who were receiving daily opioid therapy and concomitant laxatives, 33% of patients reported having stopped taking their opioid or missed or decreased a dose in order to improve constipation symptoms [10] . More than 90% of the patients who had reduced their dose or discontinued opioid therapy due to OIC reported increased pain, which had a negative impact on HRQL and day-to-day activities for the majority of these patients [10] .
OIC is clinically recognized in older patients because studies evaluating the incidence and burden of OIC have generally focused on older patients, who are typically more affected by constipation than younger patients [10, 12, 13] . In a study of the prevalence of chronic pain in a US population sample, the weighted point prevalence of all types of chronic pain evaluated (osteoarthritis pain, chronic low back pain, and other pain) was 29.7% among patients aged 35 to 44 years, 35.7% among patients aged 45 to 54 years, 38.2% among patients aged 55 to 64 years, and 38.5% among patients aged 65 years or older [16] . Given the relatively high prevalence of chronic pain among patients younger than 50 years of age (up to approximately 30%) [16] [17] [18] , there is a need to better understand the burden of OIC in younger patients. A previous study evaluated the burden of OIC in adult patients with chronic noncancer pain ranging from 18 to 85 years of age [19] . This post hoc analysis of data from that study was designed to characterize the experience of OIC in patients younger than 65 years of age, including two subgroups of patients divided by age (<50 years and 50-64 years) in order to better understand the burden of OIC in a younger patient population.
Methods

Study Design
This was a post hoc analysis of data from a 24-week, prospective, multinational, longitudinal, observational cohort study (ClinicalTrials.gov Identifier: NCT01928953), the primary outcomes of which have been published previously [15, 19] . The design of that study has been described in detail and is briefly summarized here [19] . Local institutional review boards and ethics committees approved the study protocol and informed consent forms [15] .
Patients
For the overall study, patients were recruited from outpatient primary care, pain, or specialty clinics in the United States, Canada, United Kingdom, and Germany [15, 19] . Eligible patients were adults aged 18 to 85 years who had been receiving daily opioid therapy (30-mg morphine equivalent daily dose) for chronic noncancer pain for at least four weeks. The presence of chronic pain was based on patient or health care provider (HCP) identification, not a set duration of pain. Patients were required to have experienced OIC since initiating opioid therapy. The presence of OIC was confirmed by patients meeting one or more of the following criteria reported on the baseline survey: development or worsening of constipation since starting opioid therapy; fewer than three bowel movements (BMs) per week for the previous two weeks; laxative use if the patient had three or more BMs per week for the previous two weeks; or at least one symptom of OIC (e.g., straining, hard stool, incomplete BM) of moderate or worse severity over the previous two weeks, as reported on the screening Patient Assessment of Constipation-Symptoms (PAC-SYM) questionnaire [20] . Patients were required to provide informed consent and to be able to access the Internet in order to complete web-based surveys. Patients were excluded if they had a history of idiopathic chronic constipation.
The current post hoc analysis was limited to data from patients younger than 65 years of age and included a younger subgroup (<50 years of age) and an older subgroup (50-64 years of age).
Assessments
All assessments were completed as part of a webbased patient survey at baseline and at weeks 2, 4, 6, 8, 12, 16, 20 , and 24. The presence, severity, and burden of OIC were evaluated based on the number of spontaneous BMs (SBMs), frequency of constipation symptoms, amount of bother associated with each symptom, and the PAC-SYM [20, 21] . The PAC-SYM is a validated, 12-item questionnaire that assesses the presence and severity of constipation symptoms. Each item is scored from 0 ("absent") to 4 ("very severe"). Three subscale scores (stool symptoms, abdominal symptoms, and rectal symptoms) and a PAC-SYM total score are used to summarize these 12 items. Patients also reported the types and numbers of laxatives used over the past two weeks at baseline.
The impact of OIC on HRQL, activity, and work productivity was evaluated using the Patient Assessment of Constipation-Quality of Life (PAC-QOL) questionnaire [22] , the EuroQol-5 Dimension (EQ-5D) health status questionnaire [23] [24] [25] , and the Work Productivity and Activity Impairment Questionnaire-Specific Health Problem (WPAI-SHP) [26] . The PAC-QOL is a validated 28-item questionnaire that assesses the impact of constipation on HRQL [22] . The 28 items of the PAC-QOL are grouped into four subscales (physical discomfort, psychological discomfort, worries and concerns, and satisfaction), with a possible score range of 0 to 4 for each subscale, with lower scores indicating better HRQL. The satisfaction subscale was not administered in this study; thus, only the first three of these four subscales are included in this analysis.
The EQ-5D health status questionnaire is a validated questionnaire to assess health state utilities on five dimensions of HRQL (mobility, self-care, usual activities, pain or discomfort, and anxiety or depression) [24, 25] . Each of these dimensions is rated on a three-point scale (1 ¼ "no problems" to 3 ¼ "extreme problems"), and the responses to these dimensions are summarized as an EQ-5D health status index score ranging from 0 ("dead") to 1 ("full health"). In addition, the EQ-5D includes a measure of the patient's overall health state as reported on a visual analog scale (VAS; possible score: 0 ¼ "worst imaginable health state" to 100 ¼ "best imaginable health state").
The WPAI-SHP is a six-item questionnaire that evaluates the impact of constipation on work productivity and daily activities in this study [26] . The WPAI-SHP yields four summary scores, including absenteeism (i.e., work time missed due to constipation), presenteeism (constipation-related impairment during work), overall work productivity impairment, and activity impairment (for non-work-related activities). Impairment during work and overall activity impairment are rated on an 11-point scale (0 ¼ "no effect" to 10 ¼ "completely prevented me from working or doing daily activities"). Overall work productivity impairment was a summary score for work time missed due to constipation and constipationrelated work impairment.
Additional questions regarding patients' discussions about OIC with their HCPs, reasons for not discussing OIC, and outcomes of these discussions (i.e., whether their HCP recommended treatment) were also asked.
Statistical Analyses
The data presented here represent the baseline assessments completed by patients. Descriptive statistics were used to summarize results by age subgroup.
For continuous variables, summary statistics (including mean, SD, and range) were evaluated. For categorical variables, counts and percentages were evaluated. Observed data are presented; no imputation methods were used for missing data.
Results
Patients
This analysis included a total of 419 patients. Overall, 184 of these patients were younger than 50 years of age (younger subgroup) and 235 were 50 to 64 years of age (older subgroup).
No significant differences were observed in gender, race, or body mass index (Table 1) . Slightly more than one-third of patients in both age groups were men (younger subgroup, 34.8%, 64/184; older subgroup, 38.3%, 90/235), and the majority of patients in both age subgroups were white (younger subgroup, 83.2%, 153/184; older subgroup, 84.3%, 198/235).
As expected, patients in the younger subgroup were more likely to be employed than those in the older subgroup. Overall, 40.8% (75/184) of patients in the younger subgroup and 21.7% (51/235) of patients in the older subgroup were working full-or part-time at baseline. A significantly higher proportion of patients in the younger subgroup were employed full-time at baseline compared with those in the older subgroup (29.9%, 55/184, vs 14.5%, 34/235, P < 0.0001) ( Table 1) .
A significantly higher proportion of patients in the younger subgroup reported chronic headache or migraine compared with those in the older subgroup (22.3%, 41/ 184, vs 12.3%, 29/235, P ¼ 0.0068), while a significantly lower proportion of patients in the younger subgroup reported osteoarthritis compared with those in the older subgroup (12.0%, 22/184, vs 21.3%, 50/235, P ¼ 0.0121) ( Table 1) . Otherwise, reports of the types of chronic pain were generally comparable across age subgroups.
Health ratings and pain severity ratings over the previous one and seven days were comparable for the two age subgroups. The mean duration of chronic pain was significantly shorter for patients in the younger subgroup (mean ¼ 7.7 years, SD ¼ 7.1 years) than for those in the older subgroup (mean ¼ 10.7 years, SD ¼ 9.5 years, P ¼ 0.0004), as was the mean duration of opioid medication use (mean ¼ 5.0 years, SD ¼ 4.8 years, vs mean ¼ 7.0 years, SD ¼ 6.3 years, P ¼ 0.0008).
Presentation of OIC
The self-reported frequencies of SBMs at baseline, time to onset of constipation, and interference of constipation with pain management were similar between patients in the younger and older subgroups ( Table 2) . On average, patients in both age subgroups reported having fewer † Of the 46 patients who responded "I don't know" for the duration of opioid mediation, 43 (93.5%) reported a duration of chronic pain of two or more years and three reported a duration less than two years. The mean duration of chronic pain for this group was 12.5 years (SD ¼ 10.2 years). ‡ Pain severity was rated on an 11-point NRS (0 ¼ "no pain" to 10 ¼ "worst pain you can imagine").
than two SBMs per week at baseline. More than half of all patients in both subgroups experienced OIC within up to four weeks of starting their opioid medication, with approximately one-third of all patients in both age subgroups experiencing constipation within the first week after initiating therapy. For 50.0% (87/ 174) of patients in the younger subgroup and 50.5% (111/220) of those in the older subgroup, constipation was reported as interfering moderately or completely with the opioid-related management of pain.
The use of one or more over-the-counter (OTC) laxative within the past two weeks at baseline was reported for similar proportions of patients in the younger and older subgroups (69.0%, 127/184, and 70.2%, 165/235, respectively), as was the use of one or more prescription laxatives (16.8%, 31/184, and 17.9%, 42/235, respectively). In the younger and older subgroups, respectively, 22.8% (42/184) and 28.9% (68/235) had used two or more OTC laxatives at baseline and 1.6% (3/184) and 1.3% (3/235) had used two or more prescription laxatives. Likewise, similar proportions of younger and older patients had used three or more OTC laxatives (7.6%, 14/184, and 9.8%, 23/235, respectively) and three or more prescription laxatives (0.5%, 1/184, and 0.4%, 1/235, respectively).
Severity and Burden of OIC Symptoms
Individual ratings of symptom severity were comparable at baseline for younger and older patients for analyses of PAC-SYM items and subscales and for other constipation symptoms. The majority of patients generally reported moderate symptom severity for all PAC-SYM items. Patients in the younger subgroup typically reported that OIC symptoms were more bothersome than did those in the older subgroup ( Figure 1 ). 
Effect of OIC on HRQL, Productivity, and Activity
No major differences were observed in HRQL between patient age subgroups. Mean PAC-QOL domain scores at baseline were comparable for patients in the younger and older subgroups (Figure 2) , with mean scores ranging from 1.3 to 2.0 across the three domains. The mean EQ-5D index score at baseline was approximately 0. On average, patients in the younger subgroup reported similar OIC-related impairment while working, overall work impairment, and overall activity impairment compared with patients in the older subgroup on the WPAI-SHP (Figure 3 ). The mean percent overall work impairment was approximately 30%, while the percent overall activity impairment was approximately 40% in both age subgroups. Among patients who were currently employed, patients in the younger subgroup missed an average of 5.0 hours of work in the previous week because of constipation-related problems, compared with 4.3 hours for those in the older subgroup.
Conversations About OIC with HCPs
Of the patients who had seen their HCP within the previous month, 62% of patients in the younger subgroup and approximately 66% of those in the older subgroup discussed their constipation with their HCP. Of the patients who had discussed constipation with their HCP, the HCP had offered advice for treatment to approximately 72.9% (78/107) of patients in the younger subgroup and 69.9% (102/146) of patients in the older subgroup. Among those patients who did not discuss constipation with their HCP, patients in the younger subgroup were more likely than those in the older subgroup to report being embarrassed, running out of time, or having concerns about the need to change or reduce their pain medication as the reasons for not discussing OIC (Table 3) .
Discussion
This post hoc analysis of data from a longitudinal, observational cohort study evaluated the burden of OIC in patients younger than 65 years of age with chronic pain, and included a younger subgroup (<50 years of age) and an older subgroup (50-64 years of age) in the analysis. Patients in this population had a mean duration of chronic pain of 9.4 years, and 85.9% had been experiencing pain for two or more years. Constipation, including OIC, is typically considered to be more of a problem for older patients. Nevertheless, chronic pain conditions that may require management with opioid analgesics occur in approximately 30% to 40% of individuals younger than 65 years of age [16] , and the potential burden of OIC in these patients should be addressed. In this study, OIC was associated with a substantial burden for this population of patients Figure 3 Impairment of work productivity and activity due to opioid-induced constipation at baseline by age group. WPAI-SHP ¼ Work Productivity and Activity Impairment Questionnaire-Specific Health Problem. receiving opioid therapy for chronic noncancer pain, regardless of age. On average, patients had fewer than two BMs per week, and patients most commonly experienced constipation within one week of starting opioid therapy. The majority of patients (approximately 70%) in both subgroups had used one or more OTC laxatives within the past two weeks. Constipation symptom severity was generally similar for younger and older patients, and approximately half of all patients in both age groups reported that OIC interfered with pain management. Furthermore, the impact of OIC on HRQL, based on the PAC-QOL and EQ-5D, was comparable for patients younger than 50 years of age and those 50 to 64 years of age, as was OIC-related work and activity impairment. Given that younger patients are more likely to be employed than older patients, inadequately managed OIC may have both a personal economic impact and an effect on the overall economy.
There were, however, some key differences noted between patients in the younger and older subgroups. Patients in the younger subgroup typically reported that symptoms of constipation, including abdominal pain, discomfort, and bloating, as well as difficulties with passing a BM, were more bothersome than did patients in the older subgroup. Furthermore, patients in the younger subgroup more frequently reported experiencing other side effects (e.g., nausea, reflux, and headaches) related to OIC than those in the older subgroup.
Taken together, these results indicate that patients in the younger subgroup (<50 years of age) generally experienced at least the same or a greater burden of OIC as patients in the older subgroup (50-64 years of age). The burden of OIC in these patients younger than 50 years of age may be underrecognized clinically, because previous studies evaluating the impact of OIC have generally focused on older patients [10, 12] . Furthermore, younger patients may be reluctant to discuss OIC with their HCPs, despite the fact that younger patients reported that OIC symptoms were more bothersome than did older patients. In the current study and a previous analysis of results from the overall study [15] , only about 62% to 65% of patients spoke to their HCPs about constipation during a recent visit. Although patients were continuing to experience symptoms of OIC, the most common reason that patients in either age subgroup did not speak to their HCP about constipation was that they had discussed OIC with their provider in the past. In the current post hoc analysis, a lower proportion of patients in the younger subgroup had previously discussed OIC with their HCP as compared with patients in the older subgroup. Patients in the younger subgroup expressed greater embarrassment about discussing OIC with their HCP than did those in the older subgroup. Younger patients were also more concerned about the potential that they would have to reduce or stop their pain medication in order to relieve OIC than older patients, potentially because younger patients who were employed full time could experience work-related impairment due to inadequately managed pain.
Based on these findings, HCPs may need to take a more active role in identifying and managing patients experiencing OIC, particularly younger patients, who may be reluctant to raise the topic. There are certain patient-and treatment-related factors that are associated with an increased risk for OIC (Table 4) [13, [27] [28] [29] , which may help to identify patients who are more likely to experience OIC. When initiating a conversation about OIC with younger patients taking long-term opioid therapy for chronic noncancer pain, HCPs should address several different aspects of constipation, including symptom severity, effects on HRQL, and impact on work and daily activities, with a focus on those symptoms that appear to be more bothersome for younger patients (Table 5) . Results of a previous study showed a discordance between the patients' and HCPs' understanding of the burden of OIC [15] . Those findings, along with results of the current study, indicate that improved communication between patients and HCPs is an ongoing need for patients experiencing OIC. Communication between patients and HCPs is a key component of the patients' health care experience, which is directly correlated with patient outcomes, including objectively measured efficacy and health outcomes, quality of life outcomes, and resource utilization, across different disease states [30] .
These analyses were subject to certain limitations. Although these analyses factored in age, they did not account for other aspects of aging that could impact the incidence and experience of OIC. Aging may be associated with both physiological changes and changes in perception that could affect the experience of OIC. Further investigations could provide insights into the impact of these changes in the physiology and perception of aging on the experience of constipation. Furthermore, although the structure of the questions in this webbased survey provided a specific time frame to facilitate patient responses, these questions could not reflect the full ongoing conversation between patients and HCPs regarding constipation over the duration of OIC or opioid use. Nevertheless, these findings demonstrate that patients younger than 50 years of age taking opioids for chronic noncancer pain experience a substantial burden related to OIC, one that is equivalent to or greater than that of older patients; these patients appear to be more hesitant to discuss OIC with their HCPs. By taking a more active role in addressing OIC with these patients on long-term opioid therapy, HCPs may be able to improve awareness and management of OIC, potentially leading to improvements in patient outcomes and overall HRQL. 
